ATT Attendo AB (publ)
Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or somatic care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services; and homes for people of various ages with a range of disabilities or care needs. It also provides day care, respite care and companion, meal and staffing services, as well as short term accommodation; personalized residential care for people with neuropsychiatric and psychosocial disorders; and runs family homes, crisis and emergency homes, HVB homes, dependency care, schools, and various forms of supportive housing. The company was founded in 1985 and is headquartered in Danderyd, Sweden.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Attendo (STO: ATT)
›
Attendo (STO: ATT) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 33,000 employees.
The shares were at 132.40 SEK on 19 November 2026, up 62.7% over 52 weeks. Its 52-week range is 79.30 SEK to 134.70 SEK: the price is 1.7% below the high and 67.0% above the low.
At a market capitalisation of 18.40B SEK, it trades at 18.7 times trailing earnings and 31.1 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 21% for ATT. It pays a dividend yielding 1.36% (it pays out 13% of its earnings), against a median of 0.75% among the dividend payers in that peer group.
Attendo reports return on equity of 14.9%, an operating margin of 10.6% and revenue up 3.1% year over year.
Its debt exceeds its cash by 15.73B SEK, a debt-to-equity ratio of 3.02. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 2 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 142.50 SEK is 7.6% above the current price. The next earnings report is expected on 4 February 2027.